
Utah Medical Products buys Orion for £3.6 million
- Utah Medical Products acquired UK-based Orion Medical Supplies through its Femcare subsidiary for £3.6 million.
- The acquisition is expected to add about $6 million in annual sales to Utah Medical Products.
- Orion’s harm-reduction kits are used by the NHS and other European healthcare organizations.
Utah Medical Products (NASDAQ:UTMD) announced that its Femcare subsidiary acquired all common shares of UK-based Orion Medical Supplies for £3.6 million paid from company cash reserves.
The acquisition expands Femcare’s medical device operations in the United Kingdom and adds Orion’s established harm-reduction kit business serving healthcare organizations.
Utah Medical Products said Orion’s operations will move into Femcare’s Romsey facilities, allowing the company to use existing infrastructure and reduce UK overhead costs.
The acquisition is expected to contribute approximately $6 million in annual sales.
Utah Medical Products develops and manufactures medical devices, including products used in women’s health and surgical procedures through its Femcare business.
The company said Orion’s existing relationships with the NHS and other European organizations provide a foundation for continued sales growth and potential geographic expansion.
Frequently asked questions
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue